Anti-ZEB1 antibody
1
(2 Reviews)
|
(10 Publications)
Goat Polyclonal ZEB1 antibody. Suitable for WB, ICC/IF and reacts with Mouse, Human samples. Cited in 10 publications. Immunogen corresponding to Synthetic Peptide within Human ZEB1 aa 300-350.
View Alternative Names
AREB6, TCF8, ZEB1, Zinc finger E-box-binding homeobox 1, NIL-2-A zinc finger protein, Negative regulator of IL2, Transcription factor 8, TCF-8
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-ZEB1 antibody (AB81972)
Immunofluorescence analysis of paraformaldehyde fixed U2OS cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing nuclear and cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control : Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).
- WB
Unknown
Western blot - Anti-ZEB1 antibody (AB81972)
All lanes:
Western blot - Anti-ZEB1 antibody (ab81972) at 0.05 µg/mL
All lanes:
Mouse heart tissue lysate in ripa buffer at 35 µg
Predicted band size: 124 kDa
Observed band size: 100 kDa
true
Exposure time: 1hr
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ZEB1 modulates cellular differentiation and identity by repressing and activating target genes. This protein is particularly notable for its involvement in the epithelial-to-mesenchymal transition (EMT) an important biological process for development and wound healing. ZEB1 doesn't act alone; it forms complexes with other transcription factors and co-repressors such as SMAD and CtBP enhancing its regulatory reach. Through these interactions ZEB1 influences cell adhesion molecules and cytoskeletal components facilitating cell motility and invasion.
Pathways
ZEB1 is integral to the TGF-β signaling pathway influencing cellular responses to growth factors. It also intersects with the Wnt signaling pathway linking it to cellular proliferation and differentiation. Through these pathways ZEB1 interacts with other significant proteins including β-catenin and SMAD proteins which collaboratively regulate gene expression that affects cell phenotype and behavior.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Acta biochimica et biophysica Sinica 56:564-575 PubMed38449391
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 50: PubMed37859611
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 18:171 PubMed33218341
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 11:525 PubMed32655137
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Kaohsiung journal of medical sciences 36:265-273 PubMed31889432
2020
Applications
Unspecified application
Species
Unspecified reactive species
Aging 11:10409-10421 PubMed31739286
2019
Applications
Unspecified application
Species
Unspecified reactive species
International journal of clinical and experimental 12:4066-4076 PubMed31933802
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 234:17639-17648 PubMed30854680
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncogene 37:6316-6326 PubMed30042416
2018
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 11:e0148774 PubMed26882471
2016
Applications
WB
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com